Clinical Trials Logo

Filter by:
NCT ID: NCT05848947 Completed - Clinical trials for Carcinoma, Hepatocellular

SIR-Spheres Study to Calculate the Radiation-Absorbed Dose of 99mTc-MAA

MAApping
Start date: April 25, 2023
Phase: Phase 4
Study type: Interventional

The goal of this interventional clinical trial is to evaluate the dose of radiation of Technetium-99m macroaggregated-albumin (99mTc-MAA) after an intra-arterial injection to the whole body and non-liver critical organs in patients who are undergoing evaluation for SIR-Spheres treatment for hepatocellular carcinoma.

NCT ID: NCT05848700 Completed - Schizophrenia Clinical Trials

A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With Schizophrenia

Start date: June 21, 2023
Phase: Phase 1
Study type: Interventional

A Clinical Study to learn if SEP-363856 has physical dependence in adults with schizophrenia. This study will be held in approximately 6 study sites in the United States. It will be accepting male and female participants age 18 years to 65 years. Participation will be up to approximately10 weeks.

NCT ID: NCT05848401 Completed - Long COVID Clinical Trials

Biosound Therapy as a Treatment for Long COVID Patients

Start date: April 29, 2021
Phase: N/A
Study type: Interventional

This study aimed to explore the impact of the Biosound Therapy Systerm on long COVID symptoms while determining feasibility of a future full-scale Randomized Controlled Trial. It was hypothesized that Biosound treatment would significantly improve long COVID. The goal of this clinical trial is to learn about Biosound Therapy System's impact on long COVID symptoms. The main questions it aims to answer are: - How does Biosound Therapy impact long COVID symptoms? - Is the protocol for this trial feasible for a future full-scale Randomized Controlled Trial? Participants with long COVID symptoms will be assigned to a control group and treatment group. The control group will receive no treatment. The treatment group will have 8 sessions of Biosound Therapy. Researchers will compare the treatment and control group to see if there's a difference in long COVID symptoms.

NCT ID: NCT05848206 Completed - Clinical trials for Chronic Heart Failure

Impact of Formulary Coverage of Entresto (Sacubitril/Valsartan) on Prescription Abandonment/Rejection and Subsequent Treatment and Economic Outcomes in Chronic Heart Failure Patients in the U.S.

Start date: March 11, 2022
Phase:
Study type: Observational

This was a retrospective cohort study utilizing IQVIA open-source pharmacy and medical claims data among patients with a sacubitril/valsartan (SAC/VAL) prescription transaction.

NCT ID: NCT05848128 Completed - Dry Eye Syndromes Clinical Trials

Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye

Start date: June 28, 2023
Phase: Phase 3
Study type: Interventional

The purpose of the study is to compare the efficacy and safety of 5% tavilermide ophthalmic solution to placebo for the treatment of the signs and symptoms of dry eye disease.

NCT ID: NCT05847881 Completed - Chronic Pain Clinical Trials

Toward Thriving: A Set of Reflective Tools to Empower Chronic Pain Patients and Help Them Envision a Personal Path to Thriving.

Start date: April 25, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to introduce and test the usefulness of a reflective process meant to empower people with chronic pain and help support participant's resiliency and thriving. The study team hypothesizes that: -Greater or equal to 80 percent of participants will report that the intervention was relatively easy to understand after orientation, low burden, potentially effective, and will have completed at least 2 of the 3 reflective tools.

NCT ID: NCT05847439 Completed - Healthy Volunteers Clinical Trials

A Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]BMS-986419 in Healthy Male Participants

Start date: May 5, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the pharmacokinetics (PK), metabolite profile, routes and extent of elimination, mass balance, as well as safety and tolerability of [14C]BMS-986419 in healthy male participants.

NCT ID: NCT05847413 Completed - Type 1 Diabetes Clinical Trials

Targeting Beta Cell Dysfunction With Verapamil in Longstanding T1D

Start date: May 30, 2020
Phase: Early Phase 1
Study type: Interventional

The purpose of this study is to determine whether verapamil can transiently improve beta cell function in those who do or do not secrete proinsulin and little/no C-peptide.

NCT ID: NCT05846360 Completed - Clinical trials for Respiratory Viral Infection

The Technical and Operational Performance of the QuidelOrtho Savanna RVP4 Analyzer

Start date: May 5, 2023
Phase:
Study type: Observational

The purpose of this study is for the research team to become familiar with and evaluate the technical and operational performance of the QuidelOrtho Savanna RVP4 analyzer by testing 120 archived specimens that were previously tested at the Wisconsin State Laboratory of Hygiene (WSLH) by RT-PCR and multiplex respiratory pathogen panel within the last year.

NCT ID: NCT05846178 Completed - Clinical trials for Health Knowledge, Attitudes, Practice

Digital Storytelling Intervention to Promote HPV Vaccination in Korean American Youths

Start date: March 24, 2020
Phase: N/A
Study type: Interventional

Asian American (AA) females are disproportionately affected by cervical cancer. Among AA subgroups, Korean American (KA) females had higher risks of developing cervical cancer and rates of cervical cancer mortality compared to white females (11.9, 7.1 per 100,000, respectively). Despite that HPV vaccines have shown to be efficacious in preventing cancers and are recommended for routine vaccinations for youth at age 11 or 12 years, AA females aged 9-17 years have significantly lower HPV vaccine initiation (12.4% vs 27.2%) and completion (1.9% vs 10.3%) rates compared with all other race/ethnicities combined. Using culturally grounded narratives/stories incorporating culture-specific beliefs and practices for health behavior change is effective to mitigate health disparities, specifically for Asian Americans. Storytelling, a specific form of cultural narrative, is showing promise as an effective method of facilitating healthy behaviors through promoting a sense of identification with stories and characters, and transportation (i.e., emotional engagement) as defined in the Model of Narrative as Culture-Centric Health Promotion. We propose to use a digital storytelling approach to gather in-person stories from KA immigrant mothers about HPV vaccination of their children for our intervention.